We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

302 hedge funds and large institutions have $4.58B invested in Bio-Rad Laboratories Class A in 2017 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 101 increasing their positions, 102 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 24

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

11% more funds holding

Funds holding: 271 → 302 (+31)

7% more capital invested

Capital invested by funds: $4.27B → $4.58B (+$318M)

0.34% less ownership

Funds ownership: 78.25% → 77.91% (-0.34%)

1% less repeat investments, than reductions

Existing positions increased: 101 | Existing positions reduced: 102

74% less call options, than puts

Call options by funds: $2.1M | Put options by funds: $8.14M

Holders
302
Holders Change
+31
Holders Change %
+11.44%
% of All Funds
6.85%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.16%
New
57
Increased
101
Reduced
102
Closed
24
Calls
$2.1M
Puts
$8.14M
Net Calls
-$6.04M
Net Calls Change
-$7.55M

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$52M
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$30.2M
3
SC
Samlyn Capital
New York
+$25.3M
4
PC
Polar Capital
United Kingdom
+$23.7M
5
Millennium Management
Millennium Management
New York
+$23.1M

Top Sellers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
-$62.2M
2
Bank of America
Bank of America
North Carolina
-$46.9M
3
CRM
Cramer Rosenthal McGlynn
Connecticut
-$41.4M
4
ACM
Atlanta Capital Management
Georgia
-$24.4M
5
NFA
Nationwide Fund Advisors
Ohio
-$21.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wealth Enhancement Advisory Services
226
Wealth Enhancement Advisory Services
Minnesota
$329K +$321K +1,324 New
FCM
227
Flinton Capital Management
Pennsylvania
$325K +$31K +128 +10%
TI
228
Trexquant Investment
Connecticut
$312K +$317K +1,307 New
LIM
229
Leavell Investment Management
Alabama
$310K – – –
PAM
230
Panagora Asset Management
Massachusetts
$291K – – –
ASN
231
Advisory Services Network
Georgia
$290K +$202K +835 +219%
Macquarie Group
232
Macquarie Group
Australia
$279K +$4.85K +20 +2%
Zurich Cantonal Bank
233
Zurich Cantonal Bank
Switzerland
$278K +$84.8K +350 +43%
II
234
Ibex Investors
Colorado
$263K +$264K +1,089 New
Royal Bank of Canada
235
Royal Bank of Canada
Ontario, Canada
$257K -$1.26M -5,191 -83%
Balyasny Asset Management
236
Balyasny Asset Management
Illinois
$253K +$256K +1,058 New
CIBC Asset Management
237
CIBC Asset Management
Ontario, Canada
$250K – – –
PAG
238
Private Advisor Group
New Jersey
$248K +$240K +991 New
QI
239
QS Investors
New York
$240K – – –
FQ
240
First Quadrant
California
$239K -$3.09M -12,740 -93%
NIT
241
NumerixS Investment Technologies
British Columbia, Canada
$239K -$24.2K -100 -9%
TSW
242
Thompson Siegel & Walmsley
Virginia
$238K – – –
AP
243
Advisor Partners
California
$236K +$485 +2 +0.2%
SF
244
Synovus Financial
Georgia
$233K +$969 +4 +0.4%
AWM
245
Avior Wealth Management
Nebraska
$233K +$236K +975 New
LTFS
246
Ladenburg Thalmann Financial Services
Florida
$228K -$12.4K -51 -5%
WAM
247
World Asset Management
Michigan
$224K -$20.6K -85 -8%
DY
248
Dowling & Yahnke
California
$221K -$20.1K -83 -8%
CCM
249
Cohen Capital Management
California
$215K +$218K +900 New
OI
250
Oakbrook Investments
Illinois
$209K -$206K -850 -49%
8 9
10
11 12

BIO Hedge Fund Activity: Q4 2017 in Review

302 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q4 2017, worth a combined $4.58B — up 7.5% from $4.27B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new BIO positions and 24 closed out — a net gain of 33 holders — while 101 added to existing stakes and 102 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $52M. The largest seller was Ariel Investments, cutting an estimated $62.2M.

  • 302 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q4 2017, up from 271 in Q3 2017.
  • Funds reported $4.58B of Bio-Rad Laboratories Class A stock for Q4 2017, up 7.5% quarter-over-quarter.
  • 57 funds opened new Bio-Rad Laboratories Class A positions in Q4 2017 and 24 closed out, a net change of +33 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q4 2017 was Renaissance Technologies, an estimated $52M added.
  • The largest Bio-Rad Laboratories Class A seller in Q4 2017 was Ariel Investments, an estimated $62.2M sold.

Based on aggregated 13F filings for Q4 2017.